Disease-modifying drugs for multiple sclerosis: current and future aspects
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656566.7.1.S1
Reference61 articles.
1. Multiple sclerosis
2. LUBLIN FD, REINGOLD SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisery Committee on Clinical Trials of New Agents in Multiple Sclerosis.Neurology(1996) 46(4):907-911.
3. Cost of multiple sclerosis in Europe
4. Multiple Sclerosis
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Microtubule Dynamics Following Central and Peripheral Nervous System Axotomy;ACS Chemical Neuroscience;2022-04-22
2. An insight into the role of liposomal therapeutics in the reversion of multiple sclerosis;Expert Opinion on Drug Delivery;2021-12-02
3. Catalytic Static Mixer-Enabled Hydrogenation of a Key Fenebrutinib Intermediate: Real-Time Analysis for a Stable and Scalable Process;Organic Process Research & Development;2021-07-28
4. Risk Factors for Suboptimal Medication Adherence in Persons With Multiple Sclerosis: Development of an Electronic Health Record-Based Explanatory Model for Disease-Modifying Therapy Use;Archives of Physical Medicine and Rehabilitation;2020-05
5. Who is not coming to clinic? A predictive model of excessive missed appointments in persons with multiple sclerosis;Multiple Sclerosis and Related Disorders;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3